WJB001 Capsules+Paclitaxel/Paclitaxel-albumin Clinical Trials

1 actively recruiting trial

Also known as: Wee1 inhibitor+ Taxol/Abraxane

Pipeline

Phase 1/2: 1

Top Sponsors

Wigen Biomedicine Technology (Shanghai) Co., Ltd.1

Indications

Advanced Solid Tumor1
Cancer1

Other1 trial

A Phase I/II Study of WJB001 Combination Therapy on Safety and Efficacy for Advanced Solid Tumors

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.